Auto-Brewery Syndrome Destroys Lives, Reputations Before Diagnosis Arrives

A woman pulled over in New York showed no visible signs of impairment until her blood alcohol content climbed between 0.30 and 0.40. She had not had a drink. Without any alcohol consumption, monitored over a twelve-hour period by two physician assistants and a breathalyzer expert, her BAC measured double the legal limit at 9:15 in the morning, triple it by 6 p.m., and more than four times the legal limit by 8:30 p.m., the same hour police had stopped her on the road. The judge ultimately dismissed the case. But the arrest, the legal costs, the accusations and the months of fighting to be believed: none of that could be undone.

That is auto-brewery syndrome, and for the people it strikes, the diagnosis almost always arrives far too late.

A Condition With Roots Older Than Its Name

Auto-brewery syndrome (ABS), also called gut fermentation syndrome or endogenous ethanol fermentation, occurs when fungi or bacteria colonizing the gastrointestinal tract, oral cavity, or urinary system ferment dietary sugars into ethanol. The body, in effect, brews alcohol internally, producing blood alcohol spikes with no external consumption whatsoever.

The condition's origins in the medical literature stretch back to 1887, but the first widely documented case emerged in 1948, when a five-year-old boy died after developing a perforation in his posterior abdominal wall caused by excessive gas distension, a consequence of fermentation gone catastrophically wrong. The first major case series appeared in Japan in the 1970s, where the syndrome acquired the name "meitei-sho," meaning intragastrointestinal ethanol fermentation. By 1983, Japanese researchers had formally described two case studies and catalogued 37 additional reports with similar symptoms. Since then, documented cases have surfaced in Great Britain, Egypt, and the United States, and a 2016 statement from Mayo Clinic researchers confirmed the syndrome is "afflicting people worldwide."

What Triggers the Fermentation

The biological mechanism begins with an overgrowth of fermenting organisms in the gut. Saccharomyces cerevisiae, the yeast species best known for its role in baking and brewing, is the most commonly identified pathogen in confirmed ABS cases. Normally harmless, it becomes dangerous when it proliferates unchecked, particularly in patients with Crohn's disease, short bowel syndrome, gastroparesis, or chronic intestinal obstruction. Candida species and certain rare bacteria have also been identified as causative agents.

Antibiotic use is a documented trigger: broad-spectrum antibiotics disrupt the bacterial populations that ordinarily keep yeast in check, allowing fermenting organisms to flourish. Once overgrown, those yeasts convert dietary carbohydrates into ethanol through a biochemical cascade involving pyruvate decarboxylation and alcohol dehydrogenase. Patients with ABS almost universally report high-sugar, high-carbohydrate diets, which provide the substrate the organisms need to keep fermenting.

How Lives Unravel Before Anyone Has Answers

The human cost of an undiagnosed case is severe and multi-directional. In Fall 2016, a New Jersey man named Donato was arrested for DUI after a breathalyzer registered a blood alcohol content three times the legal limit. His wife Michelle met him at the police station and told officers he had not consumed any alcohol before the arrest. The officers directed him to a hospital, where tests confirmed his BAC had not dropped after more than twelve hours under constant observation. It was only after Michelle's cousin's wife suggested looking into ABS that the couple found a gastroenterologist who could conduct a controlled diagnostic test, ultimately confirming the syndrome. The DWI charge was eventually dropped, but only after Donato retained legal counsel and underwent an extensive, costly medical workup.

These cases illustrate the pattern ABS patients routinely describe: arrests or accusations first, disbelief from family and colleagues, and eventually a grinding legal and medical battle to establish what the body has been quietly doing all along. Spouses suspect hidden drinking. Employers question fitness for work. Friends withdraw. The absence of a visible bottle does not translate, in most people's minds, into the absence of drinking.

The Diagnostic Gauntlet

Confirming ABS is painstaking by design, because the threshold for accepting such an extraordinary claim, medically and legally, must be high. A diagnosis can take up to three weeks to establish. Clinicians begin by ruling out conditions that can mimic the presentation: head injuries, hypoglycemia, seizure disorders, psychiatric diagnoses, and, critically, covert drinking. A full history gathered from family members, not just the patient, is standard practice.

Laboratory work includes a complete blood count, metabolic panel, blood alcohol level, drug screen, and crucially, stool cultures tested for both bacterial and fungal pathogens. The controlled fermentation challenge test is the evidentiary centerpiece: the patient is placed under close observation with no access to alcohol, fed a carbohydrate load, and monitored for rising BAC. Blood samples are preserved in fluoride-oxalate tubes and analyzed by headspace gas chromatography, the same methodology used in standard DWI prosecutions. A positive result requires a measurable increase in blood or breath alcohol without any possibility of external consumption. Endoscopy can further identify the responsible organisms and determine antifungal susceptibility.

False negatives are a documented risk: microbial activity fluctuates with gut pH and substrate availability, so a single negative challenge does not rule out the syndrome. Courts evaluating ABS evidence under expert witness standards increasingly require repeat testing and corroborating microbiological data before accepting the defense.

What Treatment Actually Looks Like

Once confirmed, ABS is manageable but not trivially so. Drug therapy is guided by culture and sensitivity results for the specific identified yeast or bacteria, typically involving targeted antifungal medications. Dietary intervention, specifically a significant reduction in carbohydrate intake, is the other foundational pillar: removing the fermentation substrate starves the offending organisms. Because ABS patients sometimes require antibiotics for unrelated conditions, any such course demands a follow-up plan to retest for fermenting pathogens and treat them if they resurge.

Fecal microbiota transplantation has emerged as a potential treatment, aiming to restore a healthy microbial balance that keeps fermenting organisms suppressed, though researchers note that additional study is required before it becomes standard practice.

The Legal System's Incomplete Reckoning

ABS sits in genuinely difficult legal territory. Breath and blood tests measure ethanol; they do not distinguish between ethanol consumed voluntarily and ethanol produced endogenously. A person with undiagnosed ABS and a BAC of 0.16 reads identically on a breathalyzer to someone who drank heavily, and most jurisdictions' DWI statutes were not written with endogenous fermentation in mind.

The New York dismissal established a template that defense attorneys have since worked to replicate: independent medical supervision, BAC monitoring correlated to the time of the alleged offense, and expert testimony on the mechanism of endogenous fermentation. The standard is demanding because it has to be. An ABS defense that can be assembled cheaply and without rigorous medical documentation would be trivially abused. What documented cases have shown, however, is that where the medical record is thorough and the controlled testing is properly conducted, courts can and do credit the evidence.

The deeper problem is that many cases never get that far. Patients plead guilty to avoid prolonged legal battles. Others accept job discipline or lose relationships without ever pursuing a diagnosis. ABS is still underdiagnosed largely because clinicians unfamiliar with it default to the more common explanation: the patient drank. Closing that gap, between what a rare condition can do to a person and what the medical and legal systems currently understand about it, remains the central challenge for researchers, forensic specialists, and the patients caught between.